See more : Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS) Income Statement Analysis – Financial Results
Complete financial analysis of CTT Pharmaceutical Holdings, Inc. (CTTH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CTT Pharmaceutical Holdings, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC) Income Statement Analysis – Financial Results
- ASSOCIATED CERAMICS LTD. (ASSOCER.BO) Income Statement Analysis – Financial Results
- Engie Energia Chile S.A. (ECL.SN) Income Statement Analysis – Financial Results
- Myovant Sciences Ltd. (MYOV) Income Statement Analysis – Financial Results
- Poolbeg Pharma PLC (POLB.L) Income Statement Analysis – Financial Results
CTT Pharmaceutical Holdings, Inc. (CTTH)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.cttpharmaceuticals.com
About CTT Pharmaceutical Holdings, Inc.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. The company is based in Ottawa, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 49.20K | 25.00K | 40.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.04K | 760.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 15.54K |
| Cost of Revenue | 6.40K | 6.40K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 758.74K | 0.00 | 1.07M | 27.58K | 71.62K | 0.00 | 10.70K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 76.20K |
| Gross Profit | -6.40K | -6.40K | 0.00 | 0.00 | 49.20K | 25.00K | 40.00K | 0.00 | 0.00 | 0.00 | 0.00 | -758.74K | 0.00 | -1.07M | -27.58K | -71.62K | 0.00 | -7.66K | 760.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | -60.66K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -251.97% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | -390.45% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.45M | 545.40K | -107.16K | 336.17K | 757.94K | 928.85K | 787.94K | 1.32M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 869.00 | 126.76K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 35.70K | 102.41K | 148.45K | 584.31K | 639.85K | 1.73M | 1.41M | 639.89K | 1.45M | 672.16K | -107.16K | 336.17K | 757.94K | 928.85K | 787.94K | 1.32M | 2.56M | 954.79K | 1.60M | 1.48M | 1.06M | 464.05K | 67.37K | 765.28K | 198.44K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 35.70K | 102.41K | 148.45K | 584.31K | 639.85K | 1.73M | 1.41M | 639.89K | 1.45M | 672.16K | -92.20K | 336.17K | 757.94K | 999.21K | 899.52K | 1.53M | 2.80M | 1.25M | 1.84M | 2.66M | 1.13M | 520.25K | 67.37K | 773.03K | 198.74K |
| Cost & Expenses | 42.09K | 108.80K | 148.45K | 584.31K | 639.85K | 1.73M | 1.41M | 639.89K | 1.45M | 672.16K | -92.20K | 1.09M | 757.94K | 2.07M | 927.10K | 1.60M | 2.80M | 1.26M | 1.84M | 2.66M | 1.13M | 520.25K | 67.37K | 773.03K | 274.94K |
| Interest Income | 0.00 | 0.00 | 18.05K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.65K | 53.00 | 6.67K | 18.61K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 208.00 | 18.36K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 113.00 | 0.00 |
| Depreciation & Amortization | 6.40K | 6.40K | 236.56K | 206.30K | 171.86K | 161.14K | 52.52K | 22.82K | 0.00 | -900.00K | -16.62K | 8.33K | -4.49M | 70.37K | 111.58K | 201.84K | 225.58K | 239.13K | 248.06K | 131.67K | 68.72K | 56.19K | -120.00 | 7.75K | 305.00 |
| EBITDA | -35.70K | -44.71K | -133.07K | -586.34K | -585.65K | -1.71M | -1.38M | -642.53K | -1.22M | -1.57M | 110.47K | -1.00M | -5.25M | -1.52M | -1.52M | -1.38M | -2.54M | -1.02M | -1.60M | -429.48K | -1.06M | -464.05K | -67.49K | -765.75K | -259.10K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,200.39% | -6,832.08% | -3,430.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -31,659.54% | -210,023.55% | 0.00% | 0.00% | 0.00% | 0.00% | -76,575,100.00% | -1,667.63% |
| Operating Income | -42.09K | -108.80K | -148.45K | -584.31K | -590.64K | -1.71M | -1.37M | -639.89K | -1.45M | -672.16K | 92.20K | -1.19M | -757.94K | -2.07M | -1.61M | -1.58M | -2.80M | -1.26M | -1.84M | -1.61M | -1.13M | -520.25K | -67.37K | -773.03K | -259.40K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,200.39% | -6,832.08% | -3,430.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -41,310.13% | -242,663.03% | 0.00% | 0.00% | 0.00% | 0.00% | -77,303,000.00% | -1,669.59% |
| Total Other Income/Expenses | -125.00 | 55.36K | 15.38K | -2.04K | 4.78K | -19.94K | -8.64K | -2.64K | 0.00 | 900.00K | 18.26K | 191.72K | 4.49M | 458.36K | -702.18K | 17.50K | 40.09K | 244.00 | 20.00 | 1.05M | 0.00 | 0.00 | 120.00 | -76.71K | 0.00 |
| Income Before Tax | -42.22K | -53.45K | -133.07K | -586.35K | -585.86K | -1.73M | -1.38M | -642.53K | -1.45M | 227.84K | 110.46K | -1.00M | 3.73M | -1.61M | -2.31M | -1.60M | -2.77M | -1.31M | 0.00 | 486.38K | 0.00 | 0.00 | -67.25K | -772.25K | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,190.68% | -6,911.82% | -3,451.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -43,094.70% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -77,225,000.00% | 0.00% |
| Income Tax Expense | -167.90K | -228.49K | -236.56K | -206.30K | -171.86K | -161.14K | -52.52K | -22.82K | 0.00 | 0.00 | -1.65K | -100.05K | -6.67K | -972.43K | 702.18K | -17.50K | -40.09K | -244.00 | -20.00 | -2.10M | -84.00 | -3.00 | 0.00 | -780.00 | 0.00 |
| Net Income | -42.22K | -53.45K | -133.07K | -586.35K | -585.86K | -1.73M | -1.38M | -642.53K | -1.45M | 227.84K | 110.46K | -1.00M | 3.74M | -1.10M | -1.63M | -1.58M | -2.76M | -1.26M | -1.84M | -561.15K | -1.13M | -520.24K | -67.25K | -772.25K | -259.40K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,190.68% | -6,911.82% | -3,451.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -41,302.11% | -242,660.39% | 0.00% | 0.00% | 0.00% | 0.00% | -77,225,000.00% | -1,669.59% |
| EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.04 | -0.04 | -0.03 | -0.07 | 0.01 | -0.01 | -1.07 | 4.20 | -1.30 | -2.00 | -2.27 | -4.33 | -2.16 | -3.31 | -1.37 | -2.72 | -1.09 | -4.62 | -97.09 | -54.26 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.04 | -0.04 | -0.03 | -0.07 | 0.01 | -0.01 | -1.07 | 4.00 | -1.30 | -2.00 | -2.27 | -4.33 | -2.16 | -3.31 | -1.37 | -2.72 | -1.09 | -4.62 | -97.09 | -54.26 |
| Weighted Avg Shares Out | 50.53M | 49.42M | 50.07M | 47.57M | 47.57M | 47.07M | 38.72M | 23.87M | 20.87M | 16.34M | 14.92M | 941.27K | 892.06K | 847.28K | 813.71K | 696.38K | 638.36K | 581.92K | 557.94K | 408.25K | 416.41K | 476.92K | 14.56K | 7.95K | 4.78K |
| Weighted Avg Shares Out (Dil) | 50.53M | 49.42M | 50.07M | 47.57M | 47.57M | 47.07M | 38.72M | 23.87M | 20.87M | 16.34M | 14.92M | 941.27K | 949.25K | 847.28K | 813.71K | 696.38K | 638.36K | 581.92K | 557.94K | 408.25K | 416.41K | 476.92K | 14.56K | 7.95K | 4.78K |
Source: https://incomestatements.info
Category: Stock Reports